Author: Pablo Bolaños


Oregon’s Measure 91 legalizes marijuana

July 14, 2015 By

Oregon joins Washington, Colorado, Alaska and D.C. as the only U.S. jurisdictions where the recreational use and sale of marijuana is allowed.


Day against drug abuse and illicit trafficking

June 26, 2015 By

June 26 marks the annual International Day against Drug Abuse and Illicit Trafficking established by the United Nations Office of Drugs and Crime.

We're There

Customer support improvements

June 10, 2015 By

Our new Interactive Voice Response system will provide newly updated options for all inbound calls into our 1-800-877-7484 customer support line.

Synthetic drugs

Synthetic marijuana: Catch me if you can

June 9, 2015 By

Difficult to detect and harmful if consumed, designer drugs are infiltrating society, leaving unequivocal damage in their wake.


Why does employee drug use matter?

April 27, 2015 By

Director of Science and Technology, Dr. Barry Sample highlights current drug use trends and how they affect the workplace.


Lenexa, Kansas – Quest Diagnostics’ rising star

March 9, 2015 By

Quest Diagnostics CEO Steve Rusckowski views the Lenexa, KS area as an ideal hub for some of Quest’s fastest up-and-coming businesses.


One of Fortune magazine’s most admired companies

February 20, 2015 By

With high marks for Innovation and global competitiveness, Quest stands out as the only diagnostic information services company to make the list.

Synthetic drugs

More synthetic cannabinoids elevated to Schedule I ban

February 13, 2015 By

The Drug and Alcohol Testing Administration details the addition of three synthetic cannabinoids to the Schedule I category by the DEA.


Marijuana edibles are trending with teens

December 30, 2014 By

Marijuana legislation continues to change and with it has come the jump in popularity of the edible form of the drug, now being sought out by teens.


Ebola and workplace drug testing programs

October 30, 2014 By

For our employer clients, Ebola has increased the need for clear guidelines and we outline our response to the virus related to collected specimens.